What does the evidence say about Dietary Fiber and Diabetes?

The current Migaku evidence database contains 2 reusable source documents for Dietary Fiber and Diabetes. This answer focuses on benefits, uncertainty, and practical interpretation. - However, the clinical safety, quantitative accuracy, and guideline adherence of AI-generated dietary plans remain uncertain. [Karakas PE (2026); evidence level 2] - This study aimed to evaluate systematic bias and agreement between LLM-generated diets and a guideline-concordant reference diet, and to assess whether current LLMs can function as reliable clinical nutrition decision support tools in T2DM. [Karakas PE (2026); evidence level 2] - Guideline adherence and clinical appropriateness were independently scored by registered dietitians. [Karakas PE (2026); evidence level 2] - Background/Objectives: Large language models (LLMs) are increasingly used as decision support tools in clinical nutrition, including meal planning for individuals with type 2 diabetes mellitus (T2DM). [Karakas PE (2026); evidence level 2] - By synthesizing evidence from major clinical trials and aligning with the recently released 2025-2030 Dietary Guidelines for Americans, we propose a scalable implementation framework. [Liu Q (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.